This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct 25;8(12):692.

doi: 10.1038/nrclinonc.2011.161.

Genetics: BRCA2 mutation offers response and survival advantages

Lisa Hutchinson

PMID: 22024946
DOI: 10.1038/nrclinonc.2011.161

Comment

Genetics: BRCA2 mutation offers response and survival advantages

Lisa Hutchinson. Nat Rev Clin Oncol. 2011.

. 2011 Oct 25;8(12):692.

doi: 10.1038/nrclinonc.2011.161.

Author

Lisa Hutchinson

PMID: 22024946
DOI: 10.1038/nrclinonc.2011.161

No abstract available

PubMed Disclaimer

Comment on

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, Zhang W. Yang D, et al. JAMA. 2011 Oct 12;306(14):1557-65. doi: 10.1001/jama.2011.1456. JAMA. 2011. PMID: 21990299 Free PMC article.

References

1. JAMA. 2011 Oct 12;306(14):1557-65 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal